Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Effects of Empagliflozin + Linagliptin vs Metformin + Insulin Glargine on Renal and Vascular Changes in Type 2 Diabetes (ELMI)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02752113
Recruitment Status : Completed
First Posted : April 26, 2016
Last Update Posted : July 29, 2019
Sponsor:
Collaborator:
University of Erlangen-Nürnberg Medical School
Information provided by (Responsible Party):
Institut für Pharmakologie und Präventive Medizin